Davila GW - Search Results

1

Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence.

Dmochowski RR, Sand PK, Zinner NR, Gittelman MC, Davila GW, Sanders SW; Transdermal Oxybutynin Study Group. Dmochowski RR, et al. Among authors: davila gw. Urology. 2003 Aug;62(2):237-42. doi: 10.1016/s0090-4295(03)00356-x. Urology. 2003. PMID: 12893326 Clinical Trial.

2

Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.

Dmochowski RR, Davila GW, Zinner NR, Gittelman MC, Saltzstein DR, Lyttle S, Sanders SW; Transdermal Oxybutynin Study Group. Dmochowski RR, et al. Among authors: davila gw. J Urol. 2002 Aug;168(2):580-6. J Urol. 2002. PMID: 12131314 Clinical Trial.

3

Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials.

Dmochowski RR, Nitti V, Staskin D, Luber K, Appell R, Davila GW. Dmochowski RR, et al. Among authors: davila gw. World J Urol. 2005 Sep;23(4):263-70. doi: 10.1007/s00345-005-0012-8. Epub 2005 Nov 8. World J Urol. 2005. PMID: 16151816 Clinical Trial.

4

Bladder-health diaries: an assessment of 3-day vs 7-day entries.

Dmochowski RR, Sanders SW, Appell RA, Nitti VW, Davila GW. Dmochowski RR, et al. Among authors: davila gw. BJU Int. 2005 Nov;96(7):1049-54. doi: 10.1111/j.1464-410X.2005.05785.x. BJU Int. 2005. PMID: 16225527

5

Transdermal drug delivery treatment for overactive bladder.

Dmochowski RR, Starkman JS, Davila GW. Dmochowski RR, et al. Among authors: davila gw. Int Braz J Urol. 2006 Sep-Oct;32(5):513-20. doi: 10.1590/s1677-55382006000500003. Int Braz J Urol. 2006. PMID: 17081319 Free article. Review.

6

A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence.

Davila GW, Daugherty CA, Sanders SW; Transdermal Oxybutynin Study Group. Davila GW, et al. J Urol. 2001 Jul;166(1):140-5. J Urol. 2001. PMID: 11435842 Clinical Trial.

7

Transdermal oxybutynin for overactive bladder.

Davila GW, Starkman JS, Dmochowski RR. Davila GW, et al. Urol Clin North Am. 2006 Nov;33(4):455-63, viii. doi: 10.1016/j.ucl.2006.06.005. Urol Clin North Am. 2006. PMID: 17011381

8

Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome.

Sand PK, Davila GW, Lucente VR, Thomas H, Caramelli KE, Hoel G. Sand PK, et al. Among authors: davila gw. Am J Obstet Gynecol. 2012 Feb;206(2):168.e1-6. doi: 10.1016/j.ajog.2011.08.005. Epub 2011 Aug 11. Am J Obstet Gynecol. 2012. PMID: 21963104 Clinical Trial.

9

Effectiveness of a urinary control insert in the management of stress urinary incontinence: early results of a multicenter study.

Staskin D, Bavendam T, Miller J, Davila GW, Diokno A, Knapp P, Rappaport S, Sand P, Sant G, Tutrone R. Staskin D, et al. Among authors: davila gw. Urology. 1996 May;47(5):629-36. doi: 10.1016/s0090-4295(96)00003-9. Urology. 1996. PMID: 8650857 Clinical Trial.

10

Effect of a urinary control insert on quality of life in incontinent women.

Sand PK, Staskin D, Miller J, Diokno A, Sant GR, Davila GW, Knapp P, Rappaport S, Tutrone R. Sand PK, et al. Among authors: davila gw. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(2):100-5. doi: 10.1007/pl00004016. Int Urogynecol J Pelvic Floor Dysfunct. 1999. PMID: 10384971 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters